Polycystic Ovarian Morphology may be a Positive Prognostic Factor in Patients with Endometrial Cancer who Achieved Complete Remission after Fertility-Sparing Therapy with Progestin

BACKGROUND: The most studied fertility-sparing therapy for endometrial cancer (EC) is oral progestin therapy. However, complete remission (CR) rate after progestin therapy is not enough ranging from 60 to 80 %, with high recurrence rate. Clinical features that predict treatment efficacy and recurren...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukui, Yamato, Taguchi, Ayumi, Adachi, Katsuyuki, Sato, Marie, Kawata, Akira, Tanikawa, Michihiro, Sone, Kenbun, Mori, Mayuyo, Nagasaka, Kazunori, Matsumoto, Yoko, Arimoto, Takahide, Oda, Katsutoshi, Osuga, Yutaka, Fujii, Tomoyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773799/
https://www.ncbi.nlm.nih.gov/pubmed/29172287
http://dx.doi.org/10.22034/APJCP.2017.18.11.3111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773799/
https://www.ncbi.nlm.nih.gov/pubmed/29172287
http://dx.doi.org/10.22034/APJCP.2017.18.11.3111

Ejemplares similares